CMTA Adds Science Writer Kenneth Raymond to Team
…for patients and their families. The CMTA has invested $23.5 million in the search for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with…
CMTA Announces New Center of Excellence in Thailand
…receiving her training from leading CMT specialist Michael Shy, MD, at the University of Iowa, she became interested in clinical research with children living with CMT. Her recent research includes…
CMTA Lunch & Learn: Neuro-Toxic Medication List Update
07/13/2023 @ 12:00 pm – 1:00 pm – Please join us on July 13 at 12:00 p.m. Eastern Time to hear an update on the newly reviewed and revised CMT Neuro-toxic Medication List. The CMTA funded a grant awarded to Guido Cavaletti, MD at the University of Milano-Bicocca to review and update the current CMT neuro-toxic medication list. Dr. Cavaletti and colleague, Dr. […]
CMTA to attend the annual BIO partnering conference in Boston
The CMTA is a global leader in the acceleration of CMT research and pre-clinical testing. The CMTA will be attending the BIO annual meeting in Boston and have availability for…
CMTA Hails Novartis Acquisition of DTx Pharma And Its CMT1A Therapeutic Program
…Baloh, MD, PhD, global head of neuroscience for the Novartis Institutes for BioMedical Research, said the acquisition “underscores the Novartis commitment to bringing life-changing medicines forward for patients with neuromuscular…
Novartis Secures $1.3B Deal for CMT Treatment CKD-510
…portfolio. The significance of this collaboration is underscored by the substantial financial investment and the broader landscape of CMT research. HDAC6 has long been a focal point of CMT research,…
Atlanta, GA CMTA Branch Meeting (Virtual) with Guest Speaker
04/13/2024 @ 10:00 am – 11:00 am – Please join us (virtually) for the Atlanta, GA CMTA Branch meeting on Saturday, April 13th at 10:00 am Eastern Time. During our meeting, we will welcome guest speaker Dr. Katherine Forsey, CMTA’s Chief Research Officer. She will provide an overview of CMTA-STAR Research and the Patients as Partners in Research Initiative. There will be time for […]
CMTA Spring 2024 Report: Progress and Impact that Empowers Communities
…webinars, local meetings, and a Patient and Research Summit. Sue expresses gratitude to the community for their courage, resilience, and commitment. The CMTA’s community-led outreach efforts in 2023 included successful…
CMTA Announces Addition of Health Insurance Industry Veteran Wendy Arnone to the Board of Directors
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments and a cure to patients, is pleased to announce the appointment of health…
From Gene Discovery to Gene Editing: Closing the Diagnostic Gap and Developing CRISPR/Cas9 Capabilities in CMT
…with the Inherited Neuropathies Consortium (INC), researchers at the University of Miami, led by CMTA Strategy To Accelerate Research (STAR) Board member Stephan Zuchner, MD, PhD, are working to solve…